Works matching IS 13866346 AND DT 2021 AND VI 51 AND IP 11
Results: 13
Exosomal circCMTM3 promotes the pathogenesis of hepatocellular carcinoma via angiogenesis.
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1100, doi. 10.1111/hepr.13719
- By:
- Publication type:
- Article
Metabolic dysfunction‐associated fatty liver disease and nonalcoholic fatty liver disease: Which can better identify the populations with a high risk of cardiovascular disease?
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1097, doi. 10.1111/hepr.13717
- Publication type:
- Article
MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach.
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1115, doi. 10.1111/hepr.13685
- By:
- Publication type:
- Article
Postoperative direct‐acting antiviral treatment after liver resection in patients with hepatitis C virus‐related hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1102, doi. 10.1111/hepr.13709
- By:
- Publication type:
- Article
Evaluating the liver function of patients with hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1095, doi. 10.1111/hepr.13705
- By:
- Publication type:
- Article
MET amplification as a potential therapeutic target against hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1093, doi. 10.1111/hepr.13702
- Publication type:
- Article
Atherosclerotic cardiovascular disease risk difference in metabolic dysfunction‐associated fatty liver disease and nonalcoholic fatty liver disease.
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1172, doi. 10.1111/hepr.13700
- By:
- Publication type:
- Article
Exosome circCMTM3 promotes angiogenesis and tumorigenesis of hepatocellular carcinoma through miR‐3619‐5p/SOX9.
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1139, doi. 10.1111/hepr.13692
- By:
- Publication type:
- Article
Efficacy and safety of raltitrexed‐based transcatheter arterial chemoembolization for intermediate and advanced hepatocellular carcinoma: A multicenter real‐world study.
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1153, doi. 10.1111/hepr.13708
- By:
- Publication type:
- Article
Diagnostic accuracy of hepatocellular carcinoma risk prediction models during antiviral therapy in chronic hepatitis B patients.
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1170, doi. 10.1111/hepr.13684
- By:
- Publication type:
- Article
Easy albumin–bilirubin score as a new prognostic predictor in hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1129, doi. 10.1111/hepr.13671
- By:
- Publication type:
- Article
Response to crizotinib in a patient with MET‐amplified hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1164, doi. 10.1111/hepr.13664
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1091, doi. 10.1111/hepr.13523
- Publication type:
- Article